These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30065306)

  • 1. Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities.
    Polumuri SK; Haile LA; Ireland DDC; Verthelyi D
    Sci Rep; 2018 Jul; 8(1):11477. PubMed ID: 30065306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients.
    Thacker SG; Her C; Kelley-Baker L; Ireland DDC; Manangeeswaran M; Pang ES; Verthelyi D
    Front Immunol; 2022; 13():970499. PubMed ID: 36148237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.
    Moussa EM; Kotarek J; Blum JS; Marszal E; Topp EM
    Pharm Res; 2016 Jul; 33(7):1736-51. PubMed ID: 27037576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of innate immune response modulating impurities in therapeutic proteins.
    Haile LA; Puig M; Kelley-Baker L; Verthelyi D
    PLoS One; 2015; 10(4):e0125078. PubMed ID: 25901912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity.
    Haile LA; Puig M; Polumuri SK; Ascher J; Verthelyi D
    J Pharm Sci; 2017 Mar; 106(3):751-760. PubMed ID: 27923493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?
    Sordé L; Spindeldreher S; Palmer E; Karle A
    PLoS One; 2017; 12(10):e0186046. PubMed ID: 29023507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia.
    Lok KZ; Basta M; Manzanero S; Arumugam TV
    J Neuroinflammation; 2015 Apr; 12():73. PubMed ID: 25886362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cellular immune system by intravenous immunoglobulin.
    Tha-In T; Bayry J; Metselaar HJ; Kaveri SV; Kwekkeboom J
    Trends Immunol; 2008 Dec; 29(12):608-15. PubMed ID: 18926775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of inhibitory effect of intravenous immunoglobulin on neonatal umbilical cord blood lymphocytes].
    Hao YQ; Chen TX; Zhu YZ; Li QS
    Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):438-43. PubMed ID: 16053731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells.
    Wu KH; Wu WM; Lu MY; Chiang BL
    Pediatr Allergy Immunol; 2006 Feb; 17(1):60-8. PubMed ID: 16426257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protein aggregates: an immunologic perspective.
    Rosenberg AS
    AAPS J; 2006 Aug; 8(3):E501-7. PubMed ID: 17025268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide.
    Holley CK; Cedrone E; Donohue D; Neun BW; Verthelyi D; Pang ES; Dobrovolskaia MA
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates.
    Swanson MD; Rios S; Mittal S; Soder G; Jawa V
    Front Immunol; 2022; 13():915412. PubMed ID: 35967308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human polyspecific immunoglobulin for therapeutic use induces p21/WAF-1 and Bcl-2, which may be responsible for G1 arrest and long-term survival.
    Ekberg C; Nordström E; Skansén-Saphir U; Mansouri M; Raqib R; Sundqvist VA; Fernàndez C
    Hum Immunol; 2001 Mar; 62(3):215-27. PubMed ID: 11250039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma.
    Kaufman GN; Massoud AH; Audusseau S; Banville-Langelier AA; Wang Y; Guay J; Garellek JA; Mourad W; Piccirillo CA; McCusker C; Mazer BD
    Clin Exp Allergy; 2011 May; 41(5):718-28. PubMed ID: 21255135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibitory activity of tumor necrosis factor alpha and interleukin-2 of human immunoglobulin preparations.
    Menezes MC; Benard G; Sato MN; Hong MA; Duarte AJ
    Int Arch Allergy Immunol; 1997 Dec; 114(4):323-8. PubMed ID: 9414134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intravenous immunoglobulins on intimal thickening in a mouse model of arterial injury.
    Keren G; Keren P; Barshack I; Pri-Chen S; George J
    Atherosclerosis; 2001 Nov; 159(1):77-83. PubMed ID: 11689209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells.
    Booth JS; Buza JJ; Potter A; Babiuk LA; Mutwiri GK
    Dev Comp Immunol; 2010 May; 34(5):572-8. PubMed ID: 20051250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
    Klaesson S; Ringdén O; Markling L; Remberger M; Lundkvist I
    Scand J Immunol; 1993 Nov; 38(5):477-84. PubMed ID: 8235451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.